Results 61 to 70 of about 43,640 (231)

Complete Revascularization and Survival in STEMI

open access: yesGlobal Heart, 2021
Complete revascularization (CR) of ST-elevation myocardial infarction patients with multivessel coronary artery disease (MVD) has proven better regarding combined endpoints than incomplete revascularization (IR) in recent randomized control trials with no impact on survival.To retrospectively evaluate the impact of complete CR during the index ...
Miha Sustersic   +6 more
openaire   +5 more sources

Correlation of Haemoglobin Platelet Ratio (HPR) and Leukocyte Platelet Ratio (LPR) with SYNTAX-2 Score in STEMI Patients

open access: yesJurnal Penyakit Dalam Indonesia, 2021
Introduction. Various studies have concluded the association between various markers of inflammation with the clinical outcome in STEMI patients. However, most of these markers are quite expensive and not available in healthcare facilities. Hence, we aim
Muhammad Ikhsan   +3 more
doaj   +1 more source

Aortic Dissection Presenting as a STEMI

open access: yesJournal of Education and Teaching in Emergency Medicine, 2022
N ...
Yee, Jennifer, Kendle, Andrew
openaire   +4 more sources

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro   +15 more
wiley   +1 more source

Right coronary artery originating from the left anterior descending artery, or double localized stemi with a twist: case report

open access: yesCardiologia Hungarica
In our case report, we describe an incidental finding of a congenital malformation of a coronary artery in a patient with acute coronary syndrome and we would like to present the importance of these findings.
Gábor Gergely   +3 more
doaj   +1 more source

Factors Associated with Increased Length of Stay in Post Primary Percutaneous Coronary Intervention Patients: A Scoping Review

open access: yesVascular Health and Risk Management, 2023
Firman Sugiharto,1 Yanny Trisyani,2 Aan Nuraeni,2 Ristina Mirwanti,2 Azalia Melati Putri,1 Nuraulia Aghnia Armansyah1 1Faculty of Nursing, Universitas Padjadjaran, Sumedang, Jawa Barat, Indonesia; 2Department of Critical Care and Emergency Nursing ...
Sugiharto F   +5 more
doaj  

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Hypercalcaemia Mimicking STEMI on Electrocardiography [PDF]

open access: yesCase Reports in Medicine, 2010
Acute coronary syndrome is a common cause of presentation to hospital. ST segment elevation on an electrocardiogram (ECG) is likely to be cardiac in origin, but in low-risk patients other causes must be ruled out. We describe a case of a man with hypercalcaemia, no evidence of cardiac disease, and ECG changes mimicking acute myocardial infarction ...
Joseph Donovan, Mark Jackson
openaire   +3 more sources

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén   +16 more
wiley   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy